Navigation Links
Cardica to Announce Fiscal 2010 Third Quarter Financial Results on Tuesday, May 4, 2010
Date:4/22/2010

esentation to allow for any necessary software downloads.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents at www.streetevents.com, a password-protected event management site.

About Cardica

Cardica designs and manufactures proprietary stapling devices for cardiac and endoscopic surgical procedures. Cardica's stapling technology minimizes operating time and enables minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port(R) Distal Anastomosis Systems and PAS-Port(R) Proximal Anastomosis System, for coronary artery bypass graft (CABG) surgery and has shipped over 27,000 units throughout the world. In addition, the company is developing the Cardica Microcutter ES8, a true multi-fire endoscopic stapling device designed to be used in a variety of procedures, including bariatric, thoracic and general surgery.  


'/>"/>
SOURCE Cardica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cardica Announces Fiscal 2010 Second Quarter Financial Results
2. Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress
3. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
4. Cardica to Host Investor Briefing on Revolutionizing Revascularization
5. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
6. Codexis, Inc. Announces Pricing of Initial Public Offering
7. United Therapeutics Corporation To Announce First Quarter 2010 Financial Results Before Market Open on Thursday, April 29, 2010
8. Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors
9. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
10. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
11. Kensey Nash Corporation Announces the Addition of Donald Morel, Jr., Ph.D. to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... EASTON, Mass. , Sept. 19, 2014 /PRNewswire/ ... "Company") today announced it has received and approved ... Barozyme HT48 instruments and has begun to manufacture ... the first instrument will be ready for shipment ... be built and released at a rate of ...
(Date:9/19/2014)... 19, 2014 Aufgrund der ... äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch die ... verfügbar unter pharmaserialisation.com , zeigt die Serialisierungsanforderungen ... in Kraft treten. Für international tätige ... um das "ob", sondern darum, "wann" sie die ...
(Date:9/19/2014)... and CAMBRIDGE, Mass. ... Inc. (PGDx), a provider of advanced cancer ... Medicines , a leader in discovering and developing ... today disclosed the first-ever comprehensive genomic study of ... deadly cancer of the female reproductive system, also ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
(Date:9/19/2014)... New York, NY (PRWEB) September 19, 2014 ... steam over the five years to 2014. Industry operators ... first time during the period, as well as establish ... growth is due in large part to its novelty; ... 2005. Nevertheless, in that time, industry operators have been ...
(Date:9/19/2014)... 19, 2014 Follow us ... surgical techniques, and immunosuppressant drugs to prevent rejection, ... several chronic diseases related to the heart, kidneys, ... tissue transplantation have phenomenally revolutionized the survival rate ... today represents a pivotal medical intervention for thousands ...
(Date:9/19/2014)... well in infertile land, and bear many beans that ... because most legumes have a symbiotic relationship with bacteria, ... and then supply the host plant with ammonia as ... called nodules in their roots. However, if too many ... growth of the plants, because the energy cost of ...
(Date:9/19/2014)... Lifeinsure.biz has released a new blog post presenting 5 ... medical examinations. , Life insurance riders can drive ... more advantageous. Clients can read the newly released blog ... a no medical exam life insurance policy. , ... purchase, however it is more expensive. Life insurance rates ...
(Date:9/19/2014)... September 19, 2014 Ticket Down ... for his 2014 concert tour. Concertgoers can add ... business, there are a handful of artists that are considered ... in Saginaw, MichIgan, Wonder has been a force in the ... in the music business, he has released 23 studio albums, ...
Breaking Medicine News(10 mins):Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Long-distance communication from leaves to roots 2Health News:No Medical Exam Life Insurance - Lifeinsure.biz Presents 5 Important Riders! 2Health News:Stevie Wonder Tickets: Ticket Down Slashes Ticket Prices in Seattle, Boston, New York, Atlanta, Chicago, Detroit, Philadelphia, Toronto, Las Vegas & Oakland 2Health News:Stevie Wonder Tickets: Ticket Down Slashes Ticket Prices in Seattle, Boston, New York, Atlanta, Chicago, Detroit, Philadelphia, Toronto, Las Vegas & Oakland 3
... devastating brain injury that has wiped out many of ... other peoples feelings and intentions, according to a joint ... Centre for Aging and the Brain, and York Universitys ... published in the Nov. 23, 2007 issue of Science, ...
... sleepiness, experts say, , , THURSDAY, Nov. 22 (HealthDay News) ... Thanksgiving feast aren,t rare, and experts say a number ... , It may have to do with the traditional ... a chemical known to promote sleepiness, said Donna Arand, ...
... future treatment of breast cancer have been identified by a ... the online open access journal Breast Cancer Research may focus ... , A team led by Professor Mitch Dowsett, Head of ... London and Surrey, together with colleagues from the USA, Switzerland ...
... CHICAGO, Nov. 21 The Female Health Company,(Amex: ... The Wall Street,Analyst Forum 18th Annual Analyst Conference on ... York City (on 43rd Street between 5th and,6th). The ... will,present at the conference at 11:50 a.m. Eastern Time ...
... mean more ozone, and more strain on hearts, researchers ... temperatures and high ozone levels work together to boost ... , They believe that global warming -- which brings ... the number of people who die of cardiovascular events. ...
... PICK: Pregnant women pass on the effects of smoking ... effects on fetal development. A new study in mice ... Toronto, Canada, now adds the possibility that smoking before ... of female offspring to the long list of possible ...
Cached Medicine News:Health News:People with rare type of memory loss still sensitive to others, study shows 2Health News:People with rare type of memory loss still sensitive to others, study shows 3Health News:There's More Than Turkey Behind Holiday Yawns 2Health News:Found in translation: Prioritizing research questions in breast cancer 2Health News:The Female Health Company to Present at Wall Street Analyst Forum Wednesday, November 28, 2007 2Health News:Global Warming May Trigger Rise in Heart Deaths 2Health News:Global Warming May Trigger Rise in Heart Deaths 3Health News:JCI table of contents: Nov. 21, 2007 2Health News:JCI table of contents: Nov. 21, 2007 3Health News:JCI table of contents: Nov. 21, 2007 4Health News:JCI table of contents: Nov. 21, 2007 5Health News:JCI table of contents: Nov. 21, 2007 6Health News:JCI table of contents: Nov. 21, 2007 7Health News:JCI table of contents: Nov. 21, 2007 8Health News:JCI table of contents: Nov. 21, 2007 9Health News:JCI table of contents: Nov. 21, 2007 10
Produce clean 0.75 mm round hole without tissue tags. Serrated squeeze action handle....
Target illumination for day and night testing. Glare luminance distance. The Optec 3500 remote control offers flexible positioning during test administration. Each vision tester includes 12 tests sli...
... The CSV- lOOOHGT instrument provides standardized glare testing. ... Vectorvision test faces for the evaluation of glare ... is precisely calibrated to simulate two on-coming halogen ... feet. The glare level can be adjusted to ...
Ruler S/Steel....
Medicine Products: